TF and ovarian carcinoma: Bauckman et al. [65] found that ovarian carcinoma cell lines treated with 250 μmol/L of non-transferrin bound Fe during 24 h induced mitochondrial damage, reduced expression of outer mitochondrial membrane proteins, increased ROS levels and reduced cell viability.